Page last updated: 2024-08-23

epirubicin and Anemia, Fanconi

epirubicin has been researched along with Anemia, Fanconi in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Keck, JL; Manthei, KA; Voter, AF1
Boyle, D; Bylesjo, M; Couch, FJ; Davison, TS; Deharo, S; Hill, LA; Irwin, G; James, CR; James, J; Johnston, PG; Keating, KE; Kennedy, RD; Kerr, P; Lindor, NM; McDyer, FA; Mullan, PB; Mulligan, JM; O'Brien, E; Paul Harkin, D; Proutski, V; Quinn, JE; Raji, OY; Salto-Tellez, M; Walker, SM1

Other Studies

2 other study(ies) available for epirubicin and Anemia, Fanconi

ArticleYear
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
    Journal of biomolecular screening, 2016, Volume: 21, Issue:6

    Topics: Antineoplastic Agents; DNA Damage; DNA Helicases; DNA Repair; Drug Screening Assays, Antitumor; Fanconi Anemia; High-Throughput Screening Assays; Humans; Multiprotein Complexes; Protein Interaction Maps; RecQ Helicases

2016
Identification and validation of an anthracycline/cyclophosphamide-based chemotherapy response assay in breast cancer.
    Journal of the National Cancer Institute, 2014, Volume: 106, Issue:1

    Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; DNA Damage; DNA, Neoplasm; Epirubicin; Fanconi Anemia; Female; Fluorouracil; Humans; Middle Aged; Neoadjuvant Therapy; Odds Ratio; Oligonucleotide Array Sequence Analysis; Prospective Studies

2014